Complete Filing Data
Tevogen Bio Holdings Inc. reported Stockholders Equity of -$8.23 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Tevogen Bio Holdings Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$26.3M | -$13.7M | -$60.5M | $4.4M |
| General And Administrative Expense | $15.0M | $22.5M | $4.4M | $953.1K |
| Nonoperating Income Expense | $2.2M | $5.4M | ||
| Research And Development Expense | $11.1M | $31.0M | $4.4M | |
| Operating Income Loss | -$26.1M | -$53.6M | -$8.8M | |
| Net Income Loss Available To Common Stockholders Diluted | -$26.8M | -$10.3M | -$60.5M | |
| Operating Expenses | $26.1M | $53.6M | $8.8M | |
| Net Income Loss Available To Common Stockholders Basic | -$26.8M | -$10.3M | -$60.5M | |
| Interest Expense | $184.0K | $1.2M | ||
| Interest Income Expense Net | -$195.6K | -$184.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.7M | -$5.5M | -$10.4M | -$5.9M | -$9.7M | $11.3M | -$3.9M | -$22.2M | -$30.8M | $1.6M | $207.0K | -$26.0K | -$115.00 | -$11.3K |
| General And Administrative Expense | $2.6M | $2.7M | $7.2M | $2.8M | $4.5M | $8.7M | $1.2M | $1.2M | $977.1K | $198.8K | $258.6K | $282.9K | $115.00 | $11.3K |
| Nonoperating Income Expense | $327.2K | $331.5K | $1.7M | $1.8M | $465.6K | $256.9K | ||||||||
| Research And Development Expense | $3.1M | $2.7M | $3.2M | $3.3M | $4.1M | $20.8M | $1.1M | $1.0M | $1.3M | |||||
| Operating Income Loss | -$5.7M | -$5.4M | -$10.4M | -$6.1M | -$8.6M | -$29.5M | -$2.3M | -$2.2M | -$2.3M | |||||
| Net Income Loss Available To Common Stockholders Diluted | -$5.9M | -$5.6M | -$10.5M | -$5.9M | -$6.1M | -$37.0M | -$3.9M | -$22.2M | -$30.8M | |||||
| Operating Expenses | $5.7M | $5.4M | $10.4M | $6.1M | $8.6M | $29.5M | $2.3M | $2.2M | $198.8K | $115.00 | ||||
| Net Income Loss Available To Common Stockholders Basic | -$5.6M | -$10.5M | -$5.9M | -$6.1M | $10.5M | -$3.9M | -$22.2M | -$30.8M | ||||||
| Interest Expense | $24.6K | $12.5K | $155.8K | $299.9K | $289.0K | |||||||||
| Interest Income Expense Net | -$62.3K | -$38.0K | -$12.5K | $6.00 | -$299.9K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$8.2M | -$6.7M | -$94.4M | -$34.0M | -$14.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $552.4K | $1.3M | $1.1M | $5.5M | $344.6K |
| Retained Earnings Accumulated Deficit | -$139.7M | -$113.4M | -$99.7M | -$14.8M | -$14.2M |
| Liabilities Current | $7.1M | $9.0M | $85.5M | $350.5K | $59.4K |
| Liabilities And Stockholders Equity | $4.4M | $3.5M | $5.5M | $357.1M | $352.9M |
| Liabilities | $12.6M | $10.1M | $99.9M | $15.1M | $15.2M |
| Assets | $4.4M | $3.5M | $5.5M | $357.1M | $352.9M |
| Prepaid Expense And Other Assets Current | $828.6K | $919.1K | $670.6K | $145.2K | $446.6K |
| Assets Current | $1.5M | $2.4M | $1.7M | $274.4K | $791.2K |
| Unrealized Gain Loss On Investments | $2.7M | $4.9M | |||
| Cash | $129.2K | $344.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$120.4K | -$215.4K | |||
| Assets Held In Trust Noncurrent | $16.7M | $356.9M | $351.9M | ||
| Accounts Payable And Accrued Liabilities Current | $1.1M | $210.5K | $39.4K | ||
| Deferred Offering Costs Noncurrent | $14.7M | $14.7M | $14.7M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $16.7M | $356.9M | $351.9M | ||
| Other Liabilities Current | $230.0K | $140.0K | |||
| Property Plant And Equipment Net | $170.3K | $296.4K | $458.7K | ||
| Other Assets Noncurrent | $1.1M | $575.8K | $271.1K | ||
| Operating Lease Right Of Use Asset | $1.4M | $228.5K | $469.9K | ||
| Operating Lease Liability Current | $327.7K | $229.1K | $252.7K | ||
| Common Stock Value | $402.00 | $356.00 | $12.0K | ||
| Accrued Liabilities Current | $1.5M | $1.7M | $1.1M | ||
| Accounts Payable Current | $3.3M | $5.2M | $3.4M | ||
| Temporary Equity Accretion To Redemption Value | |||||
| Operating Lease Liability Noncurrent | $1.1M | $5.8K | $234.9K | ||
| Derivative Liabilities Noncurrent | $26.5K | $87.2K | |||
| Finance Lease Right Of Use Asset Amortization | $318.6K | $241.4K | $215.1K | ||
| Notes Payable Current | $1.7M | $1.7M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$730.6K | $230.6K | -$4.4M | ||
| Convertible Notes Payable Current | $80.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$7.8M | -$9.5M | -$7.7M | -$6.2M | -$7.7M | -$5.8M | -$90.8M | -$86.9M | -$64.7M | -$14.7M | -$14.0M | -$14.3M | $13.6K | $13.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0M | $685.2K | $2.0M | $2.3M | $1.1M | $1.3M | $2.6M | $3.5M | $5.7M | $143.0K | $185.6K | $231.5K | $0.00 | $0.00 |
| Retained Earnings Accumulated Deficit | -$135.0M | -$129.3M | -$123.8M | -$103.9M | -$98.1M | -$88.4M | -$16.2M | -$15.6M | -$15.3M | -$14.7M | -$14.0M | -$14.3M | -$11.4K | |
| Liabilities Current | $6.7M | $8.1M | $8.7M | $10.4M | $10.6M | $8.9M | $1.8M | $1.5M | $667.1K | $281.8K | $259.2K | $179.0K | $153.2K | |
| Liabilities And Stockholders Equity | $4.5M | $4.3M | $4.1M | $4.3M | $3.3M | $3.4M | $26.4M | $26.4M | $25.5M | $354.5M | $353.0M | $352.8M | $166.8K | |
| Liabilities | $12.3M | $13.8M | $11.8M | $10.5M | $10.9M | $9.2M | $16.6M | $16.2M | $15.4M | $15.1M | $15.1M | $15.2M | $153.2K | |
| Assets | $4.5M | $4.3M | $4.1M | $4.3M | $3.3M | $3.4M | $26.4M | $26.4M | $25.5M | $354.5M | $353.0M | $352.8M | $166.8K | |
| Prepaid Expense And Other Assets Current | $925.8K | $1.2M | $944.1K | $1.0M | $1.2M | $923.2K | $51.9K | $143.3K | $44.8K | $275.4K | $409.1K | $502.6K | ||
| Assets Current | $2.1M | $2.1M | $3.1M | $3.5M | $2.4M | $2.4M | $399.5K | $699.3K | $97.1K | $418.5K | $594.8K | $734.2K | ||
| Unrealized Gain Loss On Investments | $334.5K | $302.5K | $1.8M | $1.7M | $327.8K | $140.9K | ||||||||
| Cash | $143.0K | $185.6K | $231.5K | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $265.5K | $189.9K | -$113.0K | $0.00 | ||||||||||
| Assets Held In Trust Noncurrent | $26.0M | $25.7M | $25.4M | $354.1M | $352.4M | $352.1M | ||||||||
| Accounts Payable And Accrued Liabilities Current | $1.0M | $694.9K | $485.1K | $171.8K | $179.2K | $129.0K | $929.00 | |||||||
| Deferred Offering Costs Noncurrent | $14.7M | $14.7M | $14.7M | $14.7M | $14.7M | $14.7M | ||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $26.0M | $25.7M | ||||||||||||
| Other Liabilities Current | $200.0K | $200.0K | ||||||||||||
| Property Plant And Equipment Net | $163.9K | $164.4K | $255.9K | $337.0K | $377.5K | $418.1K | ||||||||
| Other Assets Noncurrent | $565.9K | $565.9K | $575.8K | $133.3K | $133.3K | $133.3K | ||||||||
| Operating Lease Right Of Use Asset | $1.5M | $1.5M | $163.6K | $291.5K | $352.7K | $412.1K | ||||||||
| Operating Lease Liability Current | $327.7K | $327.7K | $170.9K | $258.5K | $268.7K | $260.6K | ||||||||
| Common Stock Value | $19.7K | $19.4K | $18.4K | $17.1K | $16.9K | $16.5K | ||||||||
| Accrued Liabilities Current | $1.2M | $1.6M | $2.0M | $1.4M | $1.8M | $1.6M | ||||||||
| Accounts Payable Current | $3.3M | $4.2M | $4.7M | $5.8M | $6.7M | $5.2M | ||||||||
| Temporary Equity Accretion To Redemption Value | $1.8M | |||||||||||||
| Operating Lease Liability Noncurrent | $1.2M | $1.2M | $42.6K | $96.8K | $166.8K | |||||||||
| Derivative Liabilities Noncurrent | $29.8K | $94.7K | $73.3K | $14.6K | $22.2K | $61.0K | ||||||||
| Finance Lease Right Of Use Asset Amortization | $64.8K | $57.8K | $51.5K | |||||||||||
| Notes Payable Current | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $691.9K | $265.5K | ||||||||||||
| Convertible Notes Payable Current | $625.7K | $625.7K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$12.3M | -$12.0M | -$8.2M | -$215.4K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$101.8K | $246.0K | $317.6K | -$446.6K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $932.0K | $171.1K | ||
| Increase Decrease In Due To Affiliates Current | $90.0K | $120.0K | ||
| Net Cash Provided By Used In Financing Activities | $11.7M | $12.2M | $3.9M | |
| Net Cash Provided By Used In Investing Activities | -$64.4K | -$133.0K | ||
| Increase Decrease In Accrued Liabilities | -$74.2K | -$681.5K | -$603.8K | |
| Increase Decrease In Accounts Payable Trade | -$2.0M | $1.7M | $1.1M | |
| Increase Decrease In Other Operating Assets | $490.0K | $511.0K | -$323.7K | |
| Share Based Compensation | $16.2M | $40.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$3.3M | -$2.2M | -$2.2M | -$113.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $25.0K | $250.1K | -$70.6K | -$50.2K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $274.6K | $89.6K | |||
| Increase Decrease In Due To Affiliates Current | $42.0K | $30.0K | $814.00 | ||
| Net Cash Provided By Used In Financing Activities | $4.0M | $2.4M | $2.5M | ||
| Net Cash Provided By Used In Investing Activities | -$133.0K | ||||
| Increase Decrease In Accrued Liabilities | $274.7K | -$800.7K | -$480.4K | ||
| Increase Decrease In Accounts Payable Trade | -$535.5K | $1.7M | $497.5K | ||
| Increase Decrease In Other Operating Assets | $68.4K | -$21.3K | |||
| Share Based Compensation | $7.3M | $26.3M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 3.3M | 2.9M | 24.8M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 3.3M | 2.9M | 24.8M | ||
| Earnings Per Share Basic | $-8.08 | $-3.50 | $-2.44 | ||
| Earnings Per Share Diluted | $-8.08 | $-3.50 | $-2.44 | ||
| Common Stock Shares Outstanding | 4.0M | 3.6M | 120.0M | 2.4M | |
| Common Stock Shares Issued | 4.0M | 3.6M | 120.0M | ||
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 196.0M | 184.3M | 161.4M | 170.2M | 154.2M | 137.3M | 120.0M | 120.0M | 120.0M | 10.3M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 196.0M | 184.3M | 161.4M | 170.2M | 154.2M | 142.4M | 120.0M | 120.0M | 120.0M | 36.0M | |||
| Earnings Per Share Basic | $-0.03 | $-0.03 | $-0.07 | $-0.03 | $-0.04 | $0.08 | $-0.03 | $-0.18 | $-0.26 | $0.00 | |||
| Earnings Per Share Diluted | $-0.03 | $-0.03 | $-0.07 | $-0.03 | $-0.04 | $-0.26 | $-0.03 | $-0.18 | $-0.26 | $0.00 | |||
| Common Stock Shares Outstanding | 197.4M | 193.7M | 183.9M | 170.8M | 168.8M | 164.6M | |||||||
| Common Stock Shares Issued | 197.4M | 193.7M | 183.9M | 170.8M | 168.8M | 164.6M | |||||||
| Common Stock Shares Authorized | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | 800.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$60.7K | $58.2K | $21.8K | -$413.3K | |
| Costs And Expenses | $2.3M | $953.1K | |||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 29.0K | 7.3K | 420.5K | ||
| Accretion Of Carrying Value To Redemption Value | -$2.8M | -$5.0M | |||
| Change In Fair Value Of Convertible Promissory Notes | $48.5M | -$50.4M | |||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.2M | $40.8M | |||
| Additional Paid In Capital | $122.6M | $97.9M | $5.2M | ||
| Stock Issued During Period Value New Issues | $4.9M | $2.8M | |||
| Adjustments To Additional Paid In Capital Mark To Market | $3.0M | ||||
| Depreciation | $190.6K | $162.2K | $163.3K | ||
| Class A Ordinary Shares | 1.3K | 145.00 | |||
| Change In Value Of Class Ordinary Shares Subject To Redemption Amount | 2.8M | 5.0M | |||
| Adjustments To Additional Paid In Capital Other | $3.5M | $275.3K | |||
| Business Combination Acquisition Related Costs | $7.5M | ||||
| Stock Issued During Period Value New Issues One | $2.8M | ||||
| Paid In Kind Interest | $187.6K | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$65.0K | $21.4K | -$13.9K | -$7.6K | -$38.8K | $32.0K | $7.3K | -$29.0K | $50.8K | -$72.5K | -$137.8K | -$116.0K | ||
| Costs And Expenses | $29.5M | $606.0K | $526.6K | $2.3M | $198.8K | $258.6K | $282.9K | $115.00 | $11.3K | |||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 36.3K | 29.0K | 58.0K | 94.3K | 166.8K | 304.5K | ||||||||
| Accretion Of Carrying Value To Redemption Value | -$334.5K | -$302.5K | -$1.8M | -$2.2M | ||||||||||
| Change In Fair Value Of Convertible Promissory Notes | $48.5M | -$1.3M | -$19.7M | $28.1M | ||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.2M | $3.2M | $7.3M | $3.3M | $4.1M | $26.3M | ||||||||
| Additional Paid In Capital | $118.3M | $111.0M | $107.2M | $90.9M | $87.6M | $76.2M | $23.8K | |||||||
| Stock Issued During Period Value New Issues | $3.1M | $4.0M | $2.8M | $25.0K | ||||||||||
| Adjustments To Additional Paid In Capital Mark To Market | $2.8M | $200.0K | ||||||||||||
| Depreciation | $40.6K | $40.6K | $39.7K | |||||||||||
| Class A Ordinary Shares | 1.3K | 1.3K | ||||||||||||
| Change In Value Of Class Ordinary Shares Subject To Redemption Amount | ||||||||||||||
| Adjustments To Additional Paid In Capital Other | $1.0M | $500.0K | $2.0M | $275.3K | ||||||||||
| Business Combination Acquisition Related Costs | $7.5M | |||||||||||||
| Stock Issued During Period Value New Issues One | $3.6M | |||||||||||||
| Paid In Kind Interest | $24.6K | $159.3K | $289.1K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.